Joel Greenblatt's SLNO Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 0 shares of Soleno Therapeutics, Inc. (SLNO) worth $0, representing 0.00% of the portfolio. First purchased in 2025-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in SLNO for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 1,572 shares. Largest reduction occurred in Q2 2026, reducing 13,702 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Soleno Therapeutics (SLNO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Soleno Therapeutics (SLNO) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -13,702 | Sold Out | 0 | $0.00 |
| Q1 2026 | +1,572 | Add 12.96% | 13,702 | $33.48 |
| Q4 2025 | +12,130 | New Buy | 12,130 | $46.30 |
Joel Greenblatt's Soleno Therapeutics Investment FAQs
Joel Greenblatt first purchased Soleno Therapeutics, Inc. (SLNO) in Q4 2025, acquiring 12,130 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Soleno Therapeutics, Inc. (SLNO) for 3 quarters since Q4 2025.
Joel Greenblatt's largest addition to Soleno Therapeutics, Inc. (SLNO) was in Q4 2025, adding 12,130 shares worth $561,619.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 0 shares of Soleno Therapeutics, Inc. (SLNO), valued at approximately $0.
As of the Q2 2026 filing, Soleno Therapeutics, Inc. (SLNO) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Soleno Therapeutics, Inc. (SLNO) was 13,702 shares, as reported at the end of Q1 2026.